Skip to main content

Articles

Page 2 of 69

  1. Much has been written and spoken about telemedicine since about two decades including an article in this journal at the start of the pandemic. It took a global catastrophe to enforce its usage across the world...

    Authors: Raju Khubchandani, Tadej Avčin and Angelo Ravelli
    Citation: Pediatric Rheumatology 2023 21:145
  2. Due to the paucity of paediatric rheumatologists in Kenya, it is paramount that we explore strategies to bridge clinical care gaps for paediatric rheumatology patients in order to promote early diagnosis, prom...

    Authors: Angela Migowa, Sasha Bernatsky, Anthony K. Ngugi, Helen E. Foster, Peterrock Muriuki, Roselyter M. Riang’a and Stanley Luchters
    Citation: Pediatric Rheumatology 2023 21:144
  3. Juvenile idiopathic arthritis (JIA) is a broad term used to describe arthritis of unknown origin. JIA commonly persists into adulthood, often causing substantial morbidity such as restricted joint function, wh...

    Authors: Yun Liu and Xuemei Tang
    Citation: Pediatric Rheumatology 2023 21:143
  4. The treatment of children with multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 infection involves immunomodulatory therapies such as IVIG and steroids. Anakinra, an interleukin-1 re...

    Authors: Esra B. Akkoyun, Zachary Most, Harita Katragadda, Andrew Yu, Lorien Nassi, Nicole Oakman, Sarah Ginsburg and Mia Maamari
    Citation: Pediatric Rheumatology 2023 21:141
  5. There is no clear data on the optimal duration of treatment with anti-interleukin-1 drugs in colchicine-resistant familial Mediterranean fever patients, as well as on the dose interval. This study aimed to ass...

    Authors: Gülşah Kavrul Kayaalp, Şengül Çağlayan, Fatma Gül Demirkan, Vafa Guliyeva, Gülçin Otar Yener, Kübra Öztürk, Ferhat Demir, Semanur Özdel, Mustafa Çakan, Hafize Emine Sönmez, Betül Sözeri and Nuray Aktay Ayaz
    Citation: Pediatric Rheumatology 2023 21:140
  6. Patients with systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD) have been under-represented in studies about safety of the COVID-19 immunization. We aimed to inquire about th...

    Authors: Mariana Correia Marques, Subrata Paul, Carol Lake, Ly-Lan Bergeron, Rashmi Sinha, Luciana Peixoto, Marinka Twilt and Michael J. Ombrello
    Citation: Pediatric Rheumatology 2023 21:139
  7. Juvenile Dermatomyositis (JDM) is a rare autoimmune disease characterized by skin and muscle inflammation. The loss of nail fold capillary end row loops (ERL) is evidence of small vessel involvement in JDM. Th...

    Authors: Amer Khojah, Gabrielle Morgan, Marisa S. Klein-Gitelman and Lauren M. Pachman
    Citation: Pediatric Rheumatology 2023 21:137
  8. Background: Rheumatic patients have a higher frequency of tuberculosis(TB) than the general population. This study aimed to describe children and adolescents with TB and rheumatic diseases(RD) who were being t...

    Authors: Lenita de Melo Lima, Adriana Rodrigues Fonseca, Clemax Couto Sant’Anna, Ana Alice Amaral Ibiapina Parente, Rafaela Baroni Aurilio and Maria de Fátima Bazhuni Pombo Sant’Anna
    Citation: Pediatric Rheumatology 2023 21:136
  9. It has been reported that the complete heart block (CHB) in neonatal lupus (NL) cannot be reversed. This study reported a case of NL-CHB that was reversed by transcutaneous pacing and repeated plasmapheresis.

    Authors: Yanfei Liu, Wanwei Li, Kun Zhou and Zhangxue Hu
    Citation: Pediatric Rheumatology 2023 21:135
  10. Juvenile Idiopathic Arthritis (JIA) is the most common form of childhood inflammatory arthritis. The disease burden of JIA is substantial as patients require specialized medical practitioners for diagnosis and...

    Authors: Niloofar Gheshlaghi, Megan Thomas, Natasha Trehan, Mark Harrison and Mary A. De Vera
    Citation: Pediatric Rheumatology 2023 21:134
  11. Pediatric musculoskeletal disorders account for 10% of first-line consultations in Tunisia. Referral delay and deficiencies in musculoskeletal screening raise a challenge to the early diagnosis and management ...

    Authors: Lassoued Ferjani Hanene, Narjess Amdouni, Rabhi Emna, Sahli Hela, Ben Abdelgheni Kaouther, Ben Nessib Dorra, Kaffel Dhia, Maatallah Kaouther and Hamdi Wafa
    Citation: Pediatric Rheumatology 2023 21:133
  12. Gain-of-function mutations in STING1 (also known as TMEM173) which result in constitutive activation of STING, have been reported to cause STING-associated vasculopathy with onset in infancy (SAVI). Although a wi...

    Authors: Jianqiang Wu, Qing Zhou, Hua Zhou and Meiping Lu
    Citation: Pediatric Rheumatology 2023 21:131
  13. Systemic lupus erythematosus is an autoimmune disease that involves multiple organ systems. One of its major complications, lupus nephritis (LN), is associated with a high mortality rate, and children-onset LN...

    Authors: Shi-jie Li, Dan-dan Ruan, Wei-zhen Wu, Min Wu, Qiu-yan Wu, Han-lu Wang, Yuan-yuan Ji, Yan-ping Zhang, Xin-fu Lin, Zhu-ting Fang, Li-sheng Liao, Jie-wei Luo, Mei-zhu Gao and Jia-bin Wu
    Citation: Pediatric Rheumatology 2023 21:130
  14. The linkage between prolactin (PRL) and systemic lupus erythematosus (SLE) is still vague. Determination of serum levels of prolactin to reveal its role in patients with SLE is the aim of the study.

    Authors: Hend Mehawed Soliman, Balsam Sherif Fahmy, Moataz Gamal Ali and Eman Shafik Shafie
    Citation: Pediatric Rheumatology 2023 21:128
  15. Insights into the immunological role of the gastrointestinal tract in autoimmune conditions have led to the investigation of diet as a potential adjunctive treatment option for juvenile idiopathic arthritis (J...

    Authors: Naima Hagström, Elin Lövestam, Afsaneh Koochek and Lillemor Berntson
    Citation: Pediatric Rheumatology 2023 21:127
  16. Connective tissue nevi (CTN) are congenital hamartomas caused by excessive proliferation of dermis components. In children, CTN can mimic juvenile localized scleroderma (JLS), an immune mediated skin disorder ...

    Authors: F. Tirelli, C. Giraudo, M. Soliani, F. Calabrese, G. Martini, P. Gisondi, A. Meneghel and Francesco Zulian
    Citation: Pediatric Rheumatology 2023 21:125
  17. Monogenic autoinflammatory diseases (AIDs) are rare inflammatory diseases caused by genetic variants. The pathogenesis is complex and treatment options are limited. This study aimed to describe the safety and ...

    Authors: Caihui Zhang, Zhongxun Yu, Sihao Gao, Mingsheng Ma, Lijuan Gou, Changyan Wang, Lin Wang, Ji Li, Linqing Zhong, Yu Zhou, Wei Wang and Hongmei Song
    Citation: Pediatric Rheumatology 2023 21:124
  18. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is associated with multiple organ involvement and leads to significant morbidity and mortality. One of the important environmental facto...

    Authors: Porntipa Suebsarakam and Dara Mairiang
    Citation: Pediatric Rheumatology 2023 21:123
  19. Hypermobile Ehlers-Danlos syndrome (hEDS) is characterized by joint and skin laxity, and often accompanied by chronic pain, dysautonomia, increased distress and, functional limitations. The journey to accurate...

    Authors: Estée C.H. Feldman, Kendra J. Homan, Sara E. Williams, Tracy V. Ting, Kenneth R. Goldschneider and Susmita Kashikar-Zuck
    Citation: Pediatric Rheumatology 2023 21:121
  20. Pediatric rheumatology faces a looming supply-demand crisis. While strategies have been proposed to address the supply shortfall, investigation into the increased demand for pediatric rheumatic care has been l...

    Authors: Daniel D Reiff, John M Bridges, Eileen C Rife, Victoria L Gennaro, Linda McAllister, Annelle Reed, Carolyn Smith, Bethany Walker, Peter Weiser, Emily A Smitherman, Matthew L Stoll, Melissa L Mannion and Randy Q Cron
    Citation: Pediatric Rheumatology 2023 21:120
  21. Sjögren’s syndrome (SS) is a rare disease with unclear diagnostic criteria among the children and adolescents. The purpose of this study is to describe the clinical features of pediatric Sjögren’s syndrome and...

    Authors: Ling Hou, Ningning Wang, Chengguang Zhao, Xiuli Wang and Yue Du
    Citation: Pediatric Rheumatology 2023 21:119
  22. We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with dise...

    Authors: Lauren M. Pachman, Gabrielle Morgan, Marisa S. Klein-Gitelman, Najah Ahsan and Amer Khojah
    Citation: Pediatric Rheumatology 2023 21:118
  23. Aicardi-Goutières syndrome (AGS) is a rare hereditary early-onset encephalopathy characterized by upregulation of the type I interferon pathway, poorly responsive to conventional immunosuppression.

    Authors: Wei Wang, Wei Wang, Siming Peng, Sihao Gao, Meiying Quan, Lijuan Gou, Changyan Wang, Zhixing Sun, Zhuo Li, Dongmei Lian and Hongmei Song
    Citation: Pediatric Rheumatology 2023 21:117
  24. Physiotherapy appears as a promising therapy option for patients with Juvenile Idiopathic Arthritis (JIA) [1, 2], but the effects of physiotherapy and jaw exercises on JIA-related orofacial symptoms remain unknow...

    Authors: Stratos Vassis, Cory M. Resnick, Mette Nørgaard, Kathleen M. Strawn, Helle Grove, Beatrice Noeldeke, Troels Herlin, Thomas Klit Pedersen and Peter Bangsgaard Stoustrup
    Citation: Pediatric Rheumatology 2023 21:116
  25. Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of rheumatic diseases, predominantly in systemic juvenile idiopathic arthritis (SJIA), and is considered as an autoinflammatory ...

    Authors: Meiping Lu, Liping Teng, Yiping Xu and Xuefeng Xu
    Citation: Pediatric Rheumatology 2023 21:115
  26. The epidemiology of Juvenile Dermatomyositis (JDM) in non-Caucasian population is poorly described. We performed a study of patients followed up in the French West Indies for JDM. We aimed to describe clinical...

    Authors: Arthur Felix, Frederique Delion, Fabienne Louis-Sidney, Lindsay Osei, Aurélie Armougon, Remi Bellance, Moustapha Dramé, Christophe Deligny, Benoit Suzon and Yves Hatchuel
    Citation: Pediatric Rheumatology 2023 21:113
  27. Anakinra is a recombinant interleukin-1 (IL-1) receptor antagonist used in systemic juvenile idiopathic arthritis (sJIA), refractory Kawasaki disease (KD) and cryopyrin-associated autoinflammatory syndrome (CA...

    Authors: Frederico Rajão Martins, André Costa Azevedo, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues and Iva Brito
    Citation: Pediatric Rheumatology 2023 21:112
  28. This paper presents insight into the scale of mental health concerns for families who have a child or young person with a diagnosis of Juvenile Idiopathic Arthritis (JIA) living in any of the four nations of t...

    Authors: Polly Livermore, S. Ainsworth, R. Beesley, S. Douglas, E. Earle, D. Wilson, L. Woolley and J. Clinch
    Citation: Pediatric Rheumatology 2023 21:111
  29. The prevalence of Celiac Disease (CD) in Juvenile Idiopathic Arthritis (JIA) has been reported to be 0.1–7% in various small studies. As a result of the limited number of research and their inconclusive result...

    Authors: Angela Taneja Kohli, Aimee O. Hersh, Lori Ponder, Lai Hin Kimi Chan, Kelly A. Rouster-Stevens, Anne E. Tebo, Subra Kugathasan, Stephen L. Guthery, John F. Bohnsack and Sampath Prahalad
    Citation: Pediatric Rheumatology 2023 21:110
  30. Pediatric uveitis is a severe inflammatory ocular condition that can lead to sight-threatening complications and can negatively impact quality of life. The retinal microcirculation is often affected in interme...

    Authors: Carlyn V. Kouwenberg, Julia Spierings, Evianne L. de Groot, Joke H. de Boer and Viera Kalinina Ayuso
    Citation: Pediatric Rheumatology 2023 21:109
  31. The objective of this initiative was to develop a treat-to-target (T2T) approach for the management of patients with Familial Mediterranean Fever (FMF), including the definition of a complex treatment target, ...

    Authors: Lisa Ehlers, Elisabeth Rolfes, Mareike Lieber, Dominik Müller, Elke Lainka, Faekah Gohar, Günter Klaus, Hermann Girschick, Jana Hörstermann, Jasmin Kümmerle-Deschner, Jürgen Brunner, Katharina Palm-Beden, Klaus Tenbrock, Lusine von Wrangel, Maria Faßhauer, Norbert Blank…
    Citation: Pediatric Rheumatology 2023 21:108
  32. In juvenile idiopathic arthritis (JIA) clinical remission is unattainable in some patients despite modern biologic disease-modifying antirheumatic drugs (bDMARD) therapy and switching bDMARD is required. The b...

    Authors: Mia Lindegaard Pedersen, Amalie Neve-Græsbøll, Troels Herlin and Mia Glerup
    Citation: Pediatric Rheumatology 2023 21:107
  33. Macrophage activation syndrome (MAS) is a severe and life-threatening syndrome associated with autoimmune diseases. The coexistence of MAS and juvenile dermatomyositis (JDM) is not well reported. This report d...

    Authors: Yong Chang, Xueyan Shan and Yongpeng Ge
    Citation: Pediatric Rheumatology 2023 21:106
  34. Musculoskeletal ultrasound is a well accessible technique to assess disease activity in children with juvenile idiopathic arthritis. Knowledge of reference values of joint structures is indispensable to differ...

    Authors: Ruth Wittoek, Céline Decock, Nele Dewaele, Lara Arnold, Pieter Baeyens, Ignace De Schrijver, Lisa Pardaens, Ioannis Raftakis, Thomas Renson, Charline Rinkin, Alexander D. J. Thooft, Tine Vanhaverbeke and Caroline Verbist
    Citation: Pediatric Rheumatology 2023 21:105
  35. Juvenile dermatomyositis (jDM) is the most common idiopathic inflammatory myopathy of childhood. Amyopathic or hypomyopathic courses have been described.

    Authors: Timmy Strauss, Claudia Günther, Anja Schnabel, Christine Wolf, Gabriele Hahn, Min Ae Lee-Kirsch and Normi Brück
    Citation: Pediatric Rheumatology 2023 21:104
  36. Paediatric rheumatic diseases cause considerable disease burden to children and their families (Moorthy LN, Peterson MGE, Hassett AL, et al, Pediatric Rheumatology 8:20, 2010). Delayed diagnosis is a significa...

    Authors: Jacqueline E. Kawishe, Anthony Ngugi, Stanley Luchters, Helen Foster and Angela Migowa
    Citation: Pediatric Rheumatology 2023 21:103
  37. To identify baseline predictors of persisting pain in children with Juvenile Idiopathic Arthritis (JIA), relative to patients with JIA who had similar baseline levels of pain but in whom the pain did not persist.

    Authors: Tara McGrath, Jaime Guzman, Lori Tucker, Natalie J. Shiff, Maryna Yaskina, Susan Tupper and Dax G. Rumsey
    Citation: Pediatric Rheumatology 2023 21:102
  38. Sweet syndrome (SS), also known as acute febrile neutrophilic dermatosis, is an immunologic syndrome characterized by widespread neutrophilic infiltration. Histiocytoid Sweet syndrome (H-SS) is a histopatholog...

    Authors: Margaret Irwin, Veeraya K. Tanawattanacharoen, Amy Turner, Mary Beth F. Son, Rebecca C. Hale, Craig D. Platt, Juan Putra, Birgitta A.R. Schmidt and Mollie G. Wasserman
    Citation: Pediatric Rheumatology 2023 21:101
  39. Throughout the COVID-19 pandemic, there have been concerns regarding the risks of infection in patients with autoimmune disease. In this study, we investigated the impact of the pandemic on patients with juven...

    Authors: Dawn M. Wahezi, Dominique Jerome, Evin Rothschild, Belina Yi, Jeffrey Dvergsten, Stacey Tarvin, Susan Kim and Tamar Rubinstein
    Citation: Pediatric Rheumatology 2023 21:100
  40. Tocilizumab is a humanized monoclonal antibody that acts as an IL-6 receptor antagonist. Intravenous tocilizumab is considered an option for children with anti-TNF refractory juvenile idiopathic arthritis-asso...

    Authors: Francesca Burlo, Cristina Tumminelli, Serena Pastore, Gabriele Stocco, Debora Curci, Marianna Lucafò, Alberto Tommasini and Andrea Taddio
    Citation: Pediatric Rheumatology 2023 21:99
  41. Systemic juvenile idiopathic arthritis (systemic JIA) is a severe disease with both systemic and joint inflammation. This study aims to identify predictors of disease evolution within the systemic JIA populati...

    Authors: M. Wallimann, K. Bouayed, E. Cannizzaro, D. Kaiser, A. Belot, E. Merlin, S. Poignant, C. Wouters, F. Hofer, T. Saurenmann, A. Koryllou, R. Carlomagno, M. Mejbri, M. Hofer and K. Theodoropoulou
    Citation: Pediatric Rheumatology 2023 21:96
  42. Although the advent of new therapeutics for juvenile idiopathic arthritis (JIA) patients has considerably lessened the impact of the disease and reduced its sequelae, the outcomes of JIA remain important in th...

    Authors: Carine Savel, Aurélie Chausset, Pauline Berland, Candy Guiguet-Auclair, Laura Cabane, Bruno Fautrel, Philippe Gaudin, Pascale Guillot, Gilles Hayem, Delphine Lafarge, Etienne Merlin, Nadine Pezière, Christelle Sordet, Sonia Trope, Anne Tournadre, Sandrine Malochet…
    Citation: Pediatric Rheumatology 2023 21:95

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    94 days submission to accept (Median)

    2023 Usage 
    1,095,144 downloads
    691 Altmetric mentions